Best Ivermectin Dosage for Humans with Cancer: Protocol Dosage Calculator (2026)

Protocol Dosage Calculator

Based on weight-based data from the 2026 oncology protocol reviews

Calculated Daily Dosages

Ivermectin (IVM): 70.0 mg
Fenbendazole (FBZ): —
Mebendazole (MBZ): —
Supportive Nutraceuticals:
Dosing Formula: 70 kg × 1.0 mg/kg = 70 mg taken once daily.
Important Clinical Caveats from the Article:
  • Bioavailability: Taking these options alongside a fat or oil carrier can significantly enhance GI track absorption.
  • Half-Life Accumulation: Ivermectin has a half-life of roughly 18 hours. Daily use causes drug accumulation in tissue over time.
  • Antioxidant Spacing: Mechanisms often rely on promoting ROS (Reactive Oxygen Species) to impact target cells. Avoid taking heavy antioxidants at the exact same time of day.

Comments

Post a Comment

Popular posts from this blog

Ivermectin for Cancer: Dr. William Makis Protocol and Others Explained (2026 Guide)

Image
Medically Reviewed by: Dr. Frank Yap, MD  |  Written by: OneDayMD Editorial Team  |  Last Updated:  October 2026 Quick Answer (AI & Search Summary) Dr. William Makis, a former Canadian nuclear-medicine/oncology physician publishes high-dose ivermectin protocols (typically 1.0–2.0 mg/kg/day) combined with benzimidazoles (fenbendazole and/or mebendazole) for cancer, based on his own case reports rather than randomized trials. A handful of small, legitimate trials are underway or planned (NCT05318469, NCT07487805/ICONIC). Anyone considering this protocol should do so only under physician supervision, with baseline and ongoing liver/kidney monitoring. Important Disclaimer: This article is for educational purposes only and does not constitute medical advice. Ivermectin, fenbendazole, and mebendazole are used off-label...
Read more

Top 20 Cancer Fighting Supplements: Evidence Based Literature Review (2026 Update)

Image
Medically reviewed by Dr. Frank Yap, MD  |  Written by OneDayMD Editorial Team  |  Last updated October 2026 Quick Answer No single dietary supplement is established as a universal cancer treatment. Of the 17 supplements reviewed here, the deepest human evidence supports vitamin D3 (with K2 and magnesium) , polysaccharide-K (PSK) from turkey tail as an add-on to chemotherapy in Japanese trials, berberine for preventing colorectal adenoma recurrence, omega-3 fatty acids , curcumin and green tea EGCG . Even these show mixed rather than uniformly positive results. Melatonin looked promising in small trials, but the largest randomized trial found no benefit in early-stage lung cancer. A few supplements, namely high-dose beta-carotene, vitamin E and long-term high-dose B6/B12 , have been linked to higher cancer risk in specific groups. No supplement replaces conventional cancer treatment, and antioxidant pills are generally discouraged during chemo...
Read more

Dr. William Makis's Recommended Ivermectin, Fenbendazole and Mebendazole Dosages for Cancer (2026)

Image
Last revised: August 2026 .  Integrative Oncology · Protocol Review A comprehensive synthesis of Dr Makis's clinical dosing regimens, benzimidazole combination strategies, the 2026 Hulscher observational cohort, pharmacokinetic rationale, safety monitoring requirements, and anonymised patient outcome data — presented with evidence grading. OneDayMD Editorial Team  |  Medically reviewed and updated  |  About Us Abstract Background: Dr William Makis MD (McGill Medicine; 110+ peer-reviewed publications) has treated cancer patients using repurposed antiparasitic agents since 2023, publicly documenting protocols and outcomes via Substack and X (@MakisMD). His approach centres on high-dose ivermectin combined with benzimidazoles and metabolic interventions, customised by cancer type and stage. Purpose: This continuously updated review synthesises Dr Makis's published...
Read more

Ivermectin, Fenbendazole & Mebendazole for Cancer: 2026 Evidence Guide

Image
A Master Guide & Reference — Evidence, Mechanisms, Clinical Trials, Case Series, Safety, and Protocols By Dr. Frank Yap, MD · Originally published July 2025 · Reviewed and substantially updated September 2026 Quick Answer Ivermectin, fenbendazole, mebendazole, and niclosamide are antiparasitic drugs with laboratory and animal evidence of anticancer activity, plus a growing body of patient-reported case reports. None of the four is an approved or established cancer treatment.  Mebendazole and niclosamide have gone further into human oncology trials than fenbendazole, but results remain mixed or inconclusive. This guide organizes the mechanistic evidence, clinical trial data, 760+ compiled case reports, safety findings, and the updated Joe Tippens Protocol into one evidence-tiered reference — with the regulatory and safety picture current as of September 2026. Table of Contents Front Matter Introduction: The Joe Tippens Story Part I — The Case for Drug Repurposing...
Read more

Exploring Ivermectin, Mebendazole and Fenbendazole as Aggressive Cancer Treatments: Research, Protocols, and Controversies (2026)

Image
Medically Reviewed by: OneDayMD Editorial Team | Evidence Synthesis & Safety Review | Last Updated: October 2026 Quick Answer Ivermectin, fenbendazole, and mebendazole are antiparasitic drugs with laboratory evidence of anticancer activity.  Together, ivermectin and mebendazole exhibit 37 distinct anticancer mechanism classes across 25 human malignancies, highlighting their exceptionally broad potential for therapeutic repurposing in oncology. Both are oral, widely available generic drugs that are well-tolerated alongside chemotherapy. Large, prospective, double-blind, parallel-group, randomized trials of combination ivermectin-mebendazole are urgently needed across a broad array of human malignancies. Patients should discuss any interest in these agents openly with their oncology team rather than self-administering veterinary or compounded formulations.  This article separates the genuine research question from the unverified claims, and outlines what to discus...
Read more

Fenbendazole and the Joe Tippens Protocol (2026): Evidence, Risks, and Current Perspective

Image
Medically Reviewed by: Dr Frank Yap, MD | Written by:     OneDayMD Editorial Team | Last Updated: September 2026 Introduction The Joe Tippens Protocol revolves around the off-label use of fenbendazole (a veterinary dewormer commonly sold as Panacur C or Safe-Guard) combined with various supplements for cancer. The Protocol has been gaining rapid interest over the past years following some  fenbendazole advanced cancer success stories . Joe Tippens popularized this approach after claiming it contributed to his remission from metastatic small-cell lung cancer in 2017. As of 2026, Joe Tippens remains alive and reports being cancer-free for over 8 years, continuing a maintenance version of the protocol. Fenbendazole is marketed for animals (e.g., Panacur C, Safe-Guard ) and has no regulatory approval for human cancer treatment . Evidence for anticancer effects is primarily preclinical or anecdotal , and clinical trials in humans are l...
Read more

Ivermectin & Fenbendazole for Lung Cancer: 63 Cases Analyzed (2026)

Image
Medically reviewed by Dr. Frank Yap, MD | Written by OneDayMD Editorial Team | First published October 1, 2026 | Updated October 17, 2026 (v3.0) Source disclosure. 48 of the 63 entries (76%) come from posts by one individual, William Makis, with an ivermectin cancer clinic in Florida. Five entries (50–54) come from Leading Edge Clinic (Dr. Pierre Kory). The rest are anonymous patient or family testimonials. None was independently verified. Quick Answer The primary case series lists 63 entries. After removing 7 non-analyzable entries and 4 duplicate patients, 52 unique lung-primary patients remain. Small cell lung cancer (SCLC): 8 patients (15.4%), Cases 1, 4, 23, 28, 30, 41, 46, 57. Biomarker-defined: 13 patients (25.0%). Four state a driver (EGFR ×3, ALK ×1); nine more imply one through a named targeted drug. None reports PD-L1, TMB or a sequencing panel. Immunotherapy: 9 patients (17.3%), plus 1 head-and-neck primary with lung metastases. Concurrent standard the...
Read more

Ivermectin Dosage for Cancer in 2026: Marik vs Makis vs Hope — What the Numbers Actually Are

Image
Medically Reviewed by: Dr Frank Yap, MD | Written by: OneDayMD Editorial Team | Last Updated: September 2026 Important disclaimer This article is educational. It is not a prescription and not a substitute for care from a licensed clinician. Ivermectin is FDA-approved for selected parasitic infections. Fenbendazole is a veterinary drug and is not approved for human use. Neither agent is approved to treat cancer. Do not self-medicate. Do not replace surgery, radiation, endocrine therapy, targeted therapy, immunotherapy, or chemotherapy that is working. High-dose daily ivermectin can cause neurologic toxicity. Any off-label use requires a physician, baseline labs, and a stop plan. Why this article exists Patients keep asking the same question: how many milligrams? The answers now disagree in public. In September 2024, Baghli, Makis, Marik and colleagues published a hybrid orthomolecular protocol in the Journal of Orthomolecular Medicine that listed ive...
Read more

Fact Check: Can Ivermectin and Fenbendazole Help Treat Cancer?

Image
Ivermectin and fenbendazole, originally developed as antiparasitic drugs, are sparking hope in the fight against cancer, fueled by inspiring stories like those shared by actor  Mel Gibson on The Joe Rogan Experience , where he celebrated friends’ remarkable recoveries. While these medications aren’t yet standard cancer treatments, early research is uncovering exciting potential. Scientists are encouraged by promising lab studies and are calling for more clinical trials to confirm their effectiveness and ensure safe use in humans, paving the way for innovative, accessible therapies that could transform lives. Introduction and Context According to a January 22, 2025 fact-check article by AFP: "The anti-parasitic drugs ivermectin and fenbendazole are not currently recommended for cancer, but posts spread across social media touting the medications after actor  Mel Gibson claimed on the Joe Rogan Experience  that they cured his friends' cases of the disease. Oncology ex...
Read more

Cancer Prevention Supplements & Diet: The I-PREVENT + ROOT Protocol (2026)

Image
Quick Answer:   The strongest and most consistent evidence supports a few core cancer-prevention strategies: do not use tobacco in any form; limit or avoid alcohol; maintain a healthy weight through a balanced diet and regular physical activity; and follow a plant-forward, high-fiber, Mediterranean-style eating pattern while minimizing ultra-processed foods and excess added sugar. Although maintaining a healthy diet, engaging in regular physical activity, and achieving a healthy weight remain cornerstones of cancer prevention, growing interest has focused on the potential role of glucagon-like peptide 1 receptor agonists (GLP-1 RAs) in reducing cancer risk (AACR Cancer Progress Report 2026). This framework merges OneDayMD's I-PREVENT Cancer Protocol with Dr. Paul Marik and Dr. Justus Hope's ROOT Protocol into a single five-layer system. Layer 1 is diet, metabolic health, and lifestyle — the original I-PREVENT foundation. Layers 2–3 are food-derived nutraceuticals (EG...
Read more

Archive

Show more